{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:11Z","timestamp":1786120271529,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Septic shock accounts for approximately 8% of PICU admissions worldwide, carries significant morbidity, and has a reported mortality rate between 5% and 50% depending upon the geographic region in which it occurs. The high morbidity and mortality of this condition have led clinicians to consider corticosteroids when usual management does not achieve hemodynamic stability. However, the evidence for or against the use of corticosteroids in pediatric septic shock is currently unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Pragmatic, multicenter, international, randomized, double-blinded, placebo-controlled interventional trial (ClinicalTrials.gov, NCT03401398).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Approximately 50 PICUs from 11 countries in North America, South America and Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Up to 500 eligible pediatric patients aged one month to 17 years and 8 months with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Patients randomized to the hydrocortisone arm receive an initial bolus of 2\u2009mg\/kg IV hydrocortisone, followed by 1\u2009mg\/kg every six hours until all vasoactive-inotropic infusions have been discontinued for at least 12\u2009h or for a maximum of 7 days. Patients randomized to the placebo arm receive an equivalent volume of normal saline with the identical dosing schedule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>The primary outcome is the frequency of new or progressive multiple-organ dysfunction syndrome up to 28 days following enrollment, death or discharge, whichever comes first. The secondary outcome is a composite of the frequency of death or greater than or equal to 25% decrease in health-related quality of life from baseline, assessed at 28 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The current Pediatric Surviving Sepsis Guidelines do not provide definitive recommendations regarding the use of corticosteroids in pediatric septic shock. Our study will be the first pediatric trial that is adequately powered to assess both potential benefits and adverse effects of corticosteroids in patients with septic shock. The results of this study will provide definitive data upon which to base future recommendations for corticosteroid administration in pediatric septic shock.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003872","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:00:26Z","timestamp":1767884426000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Stress Hydrocortisone in Pediatric Septic Shock: Protocol for a Pragmatic, Multicenter, International, Randomized, Double-Blinded, Placebo-Controlled Interventional Trial"],"prefix":"10.1097","author":[{"given":"Kusum","family":"Menon","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, ON, Canada."},{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.D.","family":"Agus","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA."},{"name":"Division of Medical Critical Care, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"O\u2019Hearn","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Coughlin-Wells","sequence":"additional","affiliation":[{"name":"Division of Medical Critical Care, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Choong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Kazzaz","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia."},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia."},{"name":"Department of Pediatrics, Ministry of the National Guard Health\u2014Affairs, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hau","family":"Lee","sequence":"additional","affiliation":[{"name":"Children\u2019s Intensive Care Unit, KK Women\u2019s and Children\u2019s Hospital, Singapore, Singapore."},{"name":"SingHealth Duke-NUS Paediatrics Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayre","family":"McNally","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, ON, Canada."},{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir R.","family":"Atreya","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."},{"name":"Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seattle Children\u2019s Research Institute, University of Washington School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wypij","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA."},{"name":"Department of Biostatistics, Harvard School of Public Health, Boston, MA."},{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry J.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seattle Children\u2019s Research Institute, University of Washington School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Stress Hydrocortisone in Pediatric Septic Shock (SHIPSS) Study Investigators, Canadian Critical Care Trials Group, and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"R1-20260618","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamapediatrics.2018.4839","article-title":"Global case-fatality rates in pediatric severe sepsis and septic shock: A systematic review and meta-analysis.","volume":"173","author":"Tan","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R2-20260618","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20260618","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PCC.0b013e318207096c","article-title":"World Federation of Pediatric Intensive Care and Critical Care Societies: Global sepsis initiative.","volume":"12","author":"Kissoon","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20260618","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PCC.0b013e31828a7287","article-title":"A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and\/or vasoactive infusion-dependent shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20260618","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/CCM.0b013e31820eb4e4","article-title":"Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor-dependent shock.","volume":"39","author":"Hebbar","year":"2011","journal-title":"Crit Care Med"},{"key":"R6-20260618","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0095-5108(18)30108-8","article-title":"Role of corticosteroids in neonatal blood pressure homeostasis.","volume":"25","author":"Sasidharan","year":"1998","journal-title":"Clin Perinatol"},{"key":"R7-20260618","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PCC.0b013e3181936ab3","article-title":"Low-dose hydrocortisone in pediatric septic shock: An exploratory study in a third world setting.","volume":"10","author":"Valoor","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20260618","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","article-title":"Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R9-20260618","doi-asserted-by":"crossref","first-page":"e112702","DOI":"10.1371\/journal.pone.0112702","article-title":"Corticosteroids and pediatric septic shock outcomes: A risk stratified analysis.","volume":"9","author":"Atkinson","year":"2014","journal-title":"PLoS One"},{"key":"R10-20260618","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.PCC.0000160596.31238.72","article-title":"A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: What is the role of steroids?","volume":"6","author":"Markovitz","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20260618","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0000000000000355","article-title":"A cohort study of pediatric shock: Frequency of corticosteroid use and association with clinical outcomes.","volume":"44","author":"Menon","year":"2015","journal-title":"Shock"},{"key":"R12-20260618","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/PCC.0000000000001237","article-title":"Hydrocortisone therapy in catecholamine-resistant pediatric septic shock: A pragmatic analysis of clinician practice and association with outcomes.","volume":"18","author":"Nichols","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20260618","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/rccm.201401-0171OC","article-title":"Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.","volume":"189","author":"Wong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20260618","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20260618","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/PEC.0000000000000561","article-title":"A survey of attitudes and practices regarding the use of steroid supplementation in pediatric sepsis.","volume":"31","author":"Carmean","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"R16-20260618","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PCC.0b013e31828a8125","article-title":"A systematic review and meta-analysis on the effect of steroids in pediatric shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20260618","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PCC.0b013e31828a8165","article-title":"Expanding the conversation regarding adjunctive corticosteroid therapy for pediatric septic shock.","volume":"14","author":"Zimmerman","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R18-20260618","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0000000000001121","article-title":"A randomized controlled trial of corticosteroids in pediatric septic shock: A pilot feasibility study.","volume":"18","author":"Menon","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20260618","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: Defining standard protocol items for clinical trials.","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"R20-20260618","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jama.2021.9941","article-title":"Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: The CONSERVE 2021 statement.","volume":"326","author":"Orkin","year":"2021","journal-title":"JAMA"},{"key":"R21-20260618","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/medethics-2012-101075","article-title":"A study of consent for participation in a non-therapeutic study in the pediatric intensive care population.","volume":"40","author":"Menon","year":"2014","journal-title":"J Med Ethics"},{"key":"R23-20260618","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/PCC.0000000000001301","article-title":"Comparison of consent models in a randomized trial of corticosteroids in pediatric septic shock.","volume":"18","author":"Menon","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R24-20260618","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/CCM.0000000000002425","article-title":"American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock.","volume":"45","author":"Davis","year":"2017","journal-title":"Crit Care Med"},{"key":"R25-20260618","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/CCM.0b013e3182257675","article-title":"Validation of a gene expression-based subclassification strategy for pediatric septic shock.","volume":"39","author":"Wong","year":"2011","journal-title":"Crit Care Med"},{"key":"R26-20260618","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock.","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20260618","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","article-title":"The PedsQL\u2122* 4.0 as a pediatric population health measure: Feasibility, reliability, and validity.","volume":"3","author":"Varni","year":"2003","journal-title":"Ambul Pediatr"},{"key":"R28-20260618","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11136-010-9730-5","article-title":"The PedsQL\u2122 Infant Scales: Feasibility, internal consistency reliability, and validity in healthy and ill infants.","volume":"20","author":"Varni","year":"2011","journal-title":"Qual Life Res"},{"key":"R29-20260618","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/00003246-200004000-00043","article-title":"Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: A multi-institutional study.","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"R30-20260618","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/CCM.0000000000001081","article-title":"Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: A new paradigm for outcomes assessment.","volume":"43","author":"Pollack","year":"2015","journal-title":"Crit Care Med"},{"key":"R31-20260618","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/PCC.0000000000000254","article-title":"Pediatric severe sepsis: Current trends and outcomes from the pediatric health information systems database.","volume":"15","author":"Ruth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R32-20260618","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CCM.0000000000004123","article-title":"Trajectory of mortality and health-related quality of life morbidity following community-acquired pediatric septic shock.","volume":"48","author":"Zimmerman","year":"2020","journal-title":"Crit Care Med"},{"key":"R33-20260618","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PCC.0b013e31828a7270","article-title":"The ideal time interval for critical care severity-of-illness assessment.","volume":"14","author":"Pollack","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R34-20260618","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2020.12.014","article-title":"Changes in hospitalization in children during COVID-19 pandemic quarantine in a single center in Turkey.","volume":"231","author":"Akcaboy","year":"2021","journal-title":"J Pediatr"},{"key":"R35-20260618","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/INF.0000000000002963","article-title":"A drop in number of hospitalizations among children with bacterial infections during the COVID-19 pandemic.","volume":"40","author":"Gavish","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20260618","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1097\/PCC.0000000000001409","article-title":"Beyond survival: Pediatric critical care interventional trial outcome measure preferences of families and healthcare professionals.","volume":"19","author":"Merritt","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"R37-20260618","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/PCC.0b013e3181a64be1","article-title":"Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit.","volume":"10","author":"Typpo","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R38-20260618","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: An update of the Pediatric Logistic Organ Dysfunction Core.","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"key":"R39-20260618","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PCC.0000000000003346","article-title":"Resuscitation with vitamin c, hydrocortisone, and thiamin in children with septic shock: A multicenter randomized pilot study.","volume":"25","author":"Schlapbach","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R40-20260618","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1097\/PCC.0000000000003674","article-title":"Resuscitation in paediatric septic shock using vitamin c and hydrocortisone (RESPOND): The respond randomized controlled trial protocol.","volume":"26","author":"Raman","year":"2025","journal-title":"Pediatr Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:52Z","timestamp":1786047772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003872","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}